GENERAL, O. Reg. 168/15
Section 23
Interpretation, etc.
Cite as GENERAL, O. Reg. 168/15, s. 23 · current to November 11, 2026 · consolidated from May 15, 2023 · read from e-Laws on November 16, 2026
The text
(1) In this Part,
“designated member” means,
(a) the member designated for a premises in accordance with section 30, or
(b) where only one member performs or may perform a procedure in a premises, that member; (“membre désigné”)
“inspector” means a person designated by the College to carry out an inspection under this Part on behalf of the College; (“inspecteur”)
“premises” means any place where a member performs or may perform a procedure; (“locaux”)
“procedure” means,
(a) any procedure by which any two or more drugs or substances listed in Table 2 or Table 5, in any combination, are mixed, reconstituted, or by any other means made into a customized therapeutic product by a member for the purpose of administration by intravenous injection to a patient, and includes the labelling of such a customized therapeutic product, or
(b) the administration of a customized therapeutic product described in clause (a) by intravenous injection to a patient by a member; (“acte”)
“Type 1 occurrence” means, with respect to a premises,
(a) the death of a patient at the premises after a procedure was performed,
(b) the death of a patient occurring within five days after a procedure was performed at the premises,
(c) any referral of a patient to emergency services within five days after a procedure was performed at the premises,
(d) any procedure performed on the wrong patient at the premises,
(e) the administration of an emergency drug to a patient immediately after a procedure was performed at the premises,
(f) the diagnosis of a patient with shock or convulsions occurring within five days after a procedure was performed at the premises,
(g) the diagnosis of a patient as being infected with a disease or any disease-causing agent after a procedure was performed at the premises, if the member forms the opinion that the patient is or may have been infected as a result of the performance of a procedure; (“situation de type 1”)
“Type 2 occurrence” means,
(a) any infection occurring in a patient in the premises after a procedure was performed at the premises,
(b) an unscheduled treatment of a patient by a member occurring within five days after a procedure was performed at the premises, or
(c) any adverse drug reaction occurring in a patient after a procedure was performed at the premises. (“situation de type 2”) O. Reg. 415/16, s. 1.
(2) Anything that may be done by the College under this Part may be done by the Council or by a committee established under clause 94 (1) (i) of the Health Professions Procedural Code. O. Reg. 415/16, s. 1.
Read the GENERAL on e-Laws ↗
Made under Naturopathy Act, 2007, S.O. 2007, c. 10, Sched. P.